Condition
Wet Macular Degeneration clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Wet Macular Degeneration clinical trials that are recruiting, at sites in 19 countries (most in Spain (2), United States (2), Brazil (1)). By phase: Phase 2/3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 19Countries
All recruiting trials (2)
-
Tiespectus (MK-8748) versus aflibercept to treat neovascular (wet) age-related macular degeneration
The study will see if tiespectus (MK-8748) works as well as aflibercept for people with newly diagnosed neovascular (wet) age-related macular degeneration.
-
Comparing tiespectus (MK-8748) with aflibercept for wet age-related macular degeneration
This study will test whether tiespectus (MK-8748) works as well as aflibercept for people with newly diagnosed neovascular (wet) age-related macular degeneration.
Related topics
Quick answers
How many Wet Macular Degeneration clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 19 countries. The most sites are in Spain (2 trials), United States (2 trials), Brazil (1 trial), Colombia (1 trial), Czechia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.